Adaptyv Bio

About Adaptyv Bio

Adaptyv Bio is a biotechnology company that operates a state-of-the-art automated laboratory for protein validation and characterization. The company provides experimental testing services specifically designed for AI-first protein engineering workflows, enabling researchers to validate computationally designed proteins with unprecedented speed and scale. Through their cloud-based platform, protein designers can submit sequences digitally and receive comprehensive experimental data including binding affinity measurements, expression levels, and thermostability assessments in as little as 2-3 weeks. Adaptyv's mission is to make proteins easier to engineer by providing the experimental infrastructure needed to close the loop between computational design and wet-lab validation. Their fully automated laboratory uses high-throughput cell-free expression systems, advanced robotics, and standardized assays to generate clean, consistent data suitable for training machine learning models. The platform serves as a 'lab-in-the-loop' solution, allowing protein design teams to rapidly iterate through multiple rounds of design, build, test, and learn cycles. The company offers transparent per-protein pricing starting from $49 for expression testing and $149 for binding assays, with comprehensive API access for programmatic experiment management. Adaptyv has validated thousands of proteins for leading protein design teams worldwide and maintains Proteinbase, an open repository of experimental protein design data. Founded by Julian Englert (CEO) and Daniel Nakhaee-Zadeh (CTO), the company is headquartered at the Biopole Life Science Campus in Lausanne, Switzerland.

Mission & Story

Clinical Focus

Medical conditions and clinical areas addressed by Adaptyv Bio.

Who It Serves

Milestones & Awards

Key Partnerships

Social & Media